# Fannin Innovation Studio

Fannin Innovation Studio is a Private Equity based in Houston, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Houston, United States
- **Region:** North America
- **Address:** Houston, TX, United States
- **Founded:** 2014
- **Assets under management:** Undisclosed
- **Website:** www.fannininnovation.com
- **LinkedIn:** https://www.linkedin.com/company/fannin

## Regulatory record

- **Reports private funds:** No

## About

Fannin is among the most active early-stage product development groups in the life sciences, with a dozen programs/platforms at different stages of development. It advances its pipeline both internally and through Fannin-founded entities with a combination of investor and grant funding. Its mission is to develop early-stage pharmaceutical and medical device assets that address vital unmet medical needs.

## Sectors

- Digital Health
- Pharmaceuticals
- Medical Devices

## People

- Leo Linbeck III — Chairman and Founder
- Atul Varadhachary — Managing Partner
- Mark Worscheh — Chief Financial Officer
- Dev Chatterjee — Managing Director

## Questions

### Who runs investment decisions at Fannin Innovation Studio?

Chairman and Founder Leo Linbeck III sets the strategic direction; day-to-day investment and product development decisions are driven by Managing Partner Atul Varadhachary, M.D., Ph.D., and Managing Director Dev Chatterjee, M.D., M.S., Ph.D. The core team includes a dedicated clinical development operations manager, scientists, and product development associates who collectively advance the pipeline.

### How does Fannin Innovation Studio source its deals?

Fannin sources exclusively through academic partnerships, collaborating with researchers at major institutions such as MD Anderson Cancer Center, Baylor College of Medicine, Texas Heart Institute, and Imperial College London. The firm embeds a product development team alongside academic inventors rather than licensing assets externally. This proprietary, relationship-driven model provides continuous access to innovations emerging from Houston’s largest research hospitals.

### Does Fannin participate in fund commitments or only direct deals?

Fannin focuses solely on direct investments into programs and entities it founds or co-develops, rather than committing capital to third-party venture funds. Its $260 million deployment figure represents capital invested across more than 35 programs, with approximately $185 million from investors and $75 million from grant funding (per firm website).

### What investment stages does Fannin typically target?

Fannin targets the earliest stages of product development — seed and startup phases, frequently beginning at the point of academic invention. The firm advances pharmaceutical and medical device programs through preclinical and clinical development, with three programs currently in clinical trials. Its model is designed to bridge the gap between university research and traditional Series A venture investment.

### How is Fannin related to its portfolio companies like Procyrion or Allterum?

Fannin serves as the founding management team and initial investor for its portfolio entities. For example, Allterum Therapeutics was formed in February 2020 to advance a therapeutic antibody from MD Anderson’s Scott K. Durum lab, with Fannin providing operational leadership and early capital. Procyrion and Pulmotect have their own CEOs and presidents but maintain shared R&D infrastructure and governance ties back to the studio.

### Where does the underlying capital come from?

Fannin does not publicly disclose its limited partner base or wealth origin. The firm’s deployable capital includes both investor commitments and non-dilutive grant funding from federal and institutional sources. Publicly confirmed partners are academic collaborators, not named financial sponsors.

## Related profiles

- [Fangyuan Capital](https://altss.com/profile/fangyuan-capital-hong-kong-limited)
- [Fanqie Capital](https://altss.com/profile/fanqie-capital)

---

Last updated: 2026-08-11T15:06:42.396Z

Canonical page: https://altss.com/profile/fannin-innovation-studio

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology